Search - tctmd.com

Displaying 241 - 260 of 328

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis

Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Shockwave Aortic Valve Remodeling: Experimental Findings and Future Clinical Applications

Presenter: Tamim Nazif, Steven J. Yakubov, Eberhard Grube

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pilot Programs to Address Reduced TAVR Access in Underserved Populations and Communities

Presenter: Randolph P. Martin, Mark J. Russo, Aaron Horne, Jr.

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

Presenter: Howard C. Herrmann, Fabian Nietlispach, Cenap Undemir, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

New Applications for the V8 Valvuloplasty Balloon

Presenter: Tamim Nazif, Steven J. Yakubov, Wesley R. Pedersen

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

Presenter: Lars Sondergaard

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Exploring the Volume-Outcome Relationship With TAVR: Influences of New Devices and Crowd Learning

Presenter: Randolph P. Martin, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

UK All-Comers

Presenter: Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The "Family" of TRUE Balloons: Design Characteristics and Clinical Applications

Presenter: Tamim Nazif, Steven J. Yakubov, Susheel K. Kodali

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR

Presenter: Howard C. Herrmann, Fabian Nietlispach, Hasan Ahmad, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Societal Impact of Access Restrictions to TAVR: Viewpoint From The Canadian Health Technology Assessment (HTA) Agency

Presenter: Randolph P. Martin, Mark J. Russo, Harindra Wijeysundera

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolut R Low-Risk

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis

Presenter: Howard C. Herrmann, Fabian Nietlispach, Futoshi Yamanaka, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Partner 3 Low-Risk

Presenter: Martin B. Leon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Improved Temporary Transvenous Pacemakers: The BioTrace Tempo Lead

Presenter: Tamim Nazif, Steven J. Yakubov

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The Clinical Operators Corner: Three Case Examples of Limitations and Frustrations With Current Imaging for Transcatheter Mitral and Tricuspid Procedures

Presenter: Rebecca T. Hahn, Christopher U. Meduri

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cases of Unusual Mechanisms of Coronary Occlusion During TAVR

Presenter: Omar Khalique

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Coronary Occlusion Following Self-Expandable Transcatheter Aortic Valve Replacement in Native Aortic Valve Regurgitation

Presenter: Howard C. Herrmann, Fabian Nietlispach, Mohamad Lazkani, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Large Hole Transfemoral Closure III: The MANTA Device

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Utility of Fusion Imaging Now and in the Future for Transcatheter Mitral and Tricuspid Procedures

Presenter: Rebecca T. Hahn, Dee Dee Wang

June 21, 2018

Advertisement

Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis

Shockwave Aortic Valve Remodeling: Experimental Findings and Future Clinical Applications

Pilot Programs to Address Reduced TAVR Access in Underserved Populations and Communities

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

New Applications for the V8 Valvuloplasty Balloon

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

Exploring the Volume-Outcome Relationship With TAVR: Influences of New Devices and Crowd Learning

UK All-Comers

The "Family" of TRUE Balloons: Design Characteristics and Clinical Applications

Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR

Societal Impact of Access Restrictions to TAVR: Viewpoint From The Canadian Health Technology Assessment (HTA) Agency

Evolut R Low-Risk

Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis

Partner 3 Low-Risk

Improved Temporary Transvenous Pacemakers: The BioTrace Tempo Lead

The Clinical Operators Corner: Three Case Examples of Limitations and Frustrations With Current Imaging for Transcatheter Mitral and Tricuspid Procedures

Cases of Unusual Mechanisms of Coronary Occlusion During TAVR

Coronary Occlusion Following Self-Expandable Transcatheter Aortic Valve Replacement in Native Aortic Valve Regurgitation

Large Hole Transfemoral Closure III: The MANTA Device

Utility of Fusion Imaging Now and in the Future for Transcatheter Mitral and Tricuspid Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content